Foxwayne Enterprises Acquisition Corp Cl A (FOXW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FOXW | LPCN | APM | ||
| Company | Foxwayne Enterprises Acquisition Corp Cl A | Lipocine Inc | Aptorum Group Ltd Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.17 | 5.74 | 5.13 | ||
| High | 10.25 | 6.30 | 5.13 | ||
| Low | 10.17 | 5.74 | 4.72 | ||
| Last | 10.25 | 6.04 | 4.75 | ||
| Change | +0.05 | +0.29 | -0.35 | ||
| % Change | +0.49% | +5.04% | -6.86% | ||
| Volume | 700 | 48,753 | 24,399 | ||
| 20-Day Average Volume | 11,285 | 32,503 | 22,765 | ||
| Previous Close | 10.20 | 5.75 | 5.10 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.27 | 5.02 | 5.18 | ||
| 20-Day Raw Stochastic | 26.12% | 86.32% | 14.53% | ||
| 20-Day Relative Strength | 50.10% | 63.67% | 43.80% | ||
| Weighted Alpha | +2.60 | +52.93 | -61.03 | ||
| Today's Opinion | 88% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 01/19/23 | +13.53% since 05/10/24 | -4.81% since 05/10/24 | ||
| Low | 10.17 on 01/27/23 | 5.11 on 05/14/24 | 4.55 on 05/15/24 | ||
| High | 10.74 on 01/20/23 | 6.30 on 05/17/24 | 5.27 on 05/13/24 | ||
| 1-Month | |||||
| %Chg | +1.08% since 12/27/22 | +13.53% since 04/17/24 | -34.48% since 04/17/24 | ||
| Low | 10.14 on 12/30/22 | 4.40 on 04/24/24 | 4.50 on 05/08/24 | ||
| High | 10.74 on 01/20/23 | 6.30 on 05/17/24 | 7.05 on 04/18/24 | ||
| 3-Month | |||||
| %Chg | +0.99% since 10/26/22 | +50.62% since 02/16/24 | +154.01% since 02/16/24 | ||
| Low | 10.00 on 11/25/22 | 3.20 on 03/07/24 | 1.40 on 03/05/24 | ||
| High | 10.74 on 01/20/23 | 7.15 on 04/11/24 | 17.49 on 03/06/24 | ||
| 6-Month | |||||
| %Chg | +0.20% since 07/27/22 | +118.05% since 11/17/23 | +182.74% since 11/17/23 | ||
| Low | 10.00 on 11/25/22 | 2.38 on 11/30/23 | 1.35 on 02/07/24 | ||
| High | 10.74 on 01/20/23 | 7.15 on 04/11/24 | 17.49 on 03/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 29,020 | 30,750 | 26,427 | ||
| Shares Outstanding, K | 2,831 | 5,348 | 5,182 | ||
| Annual Sales | 0 | -2,850,000 | 430,000 | ||
| Annual Net Income | -1,050,000 | -16,350,000 | -2,820,000 | ||
| Last Quarter Sales | 0 | 7,620,000 | N/A | ||
| Last Quarter Net Income | -376,199 | 3,510,000 | N/A | ||
| 60-Month Beta | 0.09 | 1.11 | 0.85 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.66 on 05/09/24 | N/A | ||
| Latest Earnings Date | N/A | 05/09/24 | 04/26/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||